CAPRICOR THERAPEUTICS INC. - COMMON STOCK
18.62
22-11月-24 16:44:58
15 分の遅延
株式
+0.83
+4.67%
本日の幅
17.51 - 18.88
ISIN
N/A
ソース
NASDAQ
-
02 3 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
25 1 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
19 1 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform
12 1 2023 09:26:27 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
03 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
06 10 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at Upcoming Investor Conferences
07 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
10 8 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
03 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
19 7 2022 09:15:00 提供 Nasdaq GlobeNewswire
-
17 6 2022 09:00:00 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
25 5 2022 09:00:02 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 5 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
10 5 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
03 5 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
29 3 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
28 3 2022 08:30:00 提供 Nasdaq GlobeNewswire